Gene · 4507
Papers2,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Merlin Immunohistochemistry Is Useful in the Differential Diagnosis of Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia. | Pathol Int | 2026 | 41410266 | PubTator, text mining | PubMed |
| Discovery of novel selective PRMT5-MTA inhibitors through structure-based virtual screening. | Bioorg Chem | 2026 | 41406787 | PubTator, text mining | PubMed |
| Utility of Morphologic Risk Stratification Modeling and Immunohistochemical Surrogates for Key Molecular Alterations in Uterine Leiomyosarcoma. | Int J Gynecol Pathol | 2026 | 41396183 | PubTator, text mining | PubMed |
| Immunohistochemical characterization of peritoneal inclusion cysts with squamous metaplasia. | Histopathology | 2026 | 41392656 | PubTator, text mining | PubMed |
| Current status and prospects of methylthioadenosine phosphorylase/protein arginine methyltransferase 5 target therapy. | Biochem Pharmacol | 2026 | 41314432 | PubTator, text mining | PubMed |
| Clinical Impact of MTAP Rearrangement in Pediatric Acute Lymphoblastic Leukemia: Insights From Whole Transcriptome Analysis. | Pediatr Blood Cancer | 2026 | 41261957 | PubTator, text mining | PubMed |
| Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC. | J Thorac Oncol | 2026 | 41260457 | PubTator, text mining | PubMed |
| Lung Carcinoma Metastatic to the Breast: A Comprehensive Analysis of Clinical Presentation, Morphologic, and Molecular Features, With Emphasis on Diagnostic Pitfalls. | Mod Pathol | 2026 | 41241092 | PubTator, text mining | PubMed |
| Precision Oncology in Pancreatic Cancer and Future Treatment Directions. | Surg Oncol Clin N Am | 2026 | 41233068 | PubTator, text mining | PubMed |
| Mesothelioma in Situ With a TP53 Mutation. | Am J Surg Pathol | 2026 | 41221650 | PubTator, text mining | PubMed |
| Comparison of Cytoplasmic and Nuclear MTAP Loss in Pleural Effusion Cytology: Correlation With Homozygous p16/CDKN2A Deletion. | Cytopathology | 2026 | 41212604 | PubTator, text mining | PubMed |
| MTAP Loss Correlates With Favorable Prognosis in HPV-independent, p16-negative Oropharyngeal Squamous Cell Carcinoma. | Am J Surg Pathol | 2026 | 41199135 | PubTator, text mining | PubMed |
| Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancer. | Biochim Biophys Acta Mol Cell Res | 2026 | 41101730 | PubTator, text mining | PubMed |
| "Letter to the editor: MTAP and p16 as immunohistochemical surrogates of CDKN2A/B homozygous deletion in central nervous system tumors: A multicentre Italian experience."- Reply. | Ann Diagn Pathol | 2026 | 41005184 | PubTator, text mining | PubMed |
| SOX2 Is the Most Sensitive Biomarker in Testicular and Gynecologic Embryonic-type Neuroectodermal Tumors (ENT) Based on a Comprehensive Evaluation of Biomarker Expression. | Am J Surg Pathol | 2026 | 40922405 | PubTator, text mining | PubMed |
| "Letter to the editor: MTAP and p16 as immunohistochemical surrogates of CDKN2A/B homozygous deletion in central nervous system tumors: A multicentre Italian experience." | Ann Diagn Pathol | 2026 | 40896970 | PubTator, text mining | PubMed |
| MTAP Expression by Immunohistochemistry: A Novel Biomarker in NSCLC. | J Thorac Oncol | 2026 | 40850616 | PubTator, text mining | PubMed |
| Polyamines in Cancer: Mechanisms, Metabolic Targets, and Therapeutic Opportunities. | Anticancer Agents Med Chem | 2026 | 40685729 | PubTator, text mining | PubMed |
| Exploiting Synthetic Lethality of PRMT5 for Precision Treatment of MTAP-Deficient Glioblastoma. | Int J Transl Med (Basel) | 2025 | 42021873 | PubTator, text mining | PubMed |
| Distinction of thymic carcinoma and type B3 thymoma using ancillary biomarkers. | Pathologica | 2025 | 41954343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4507/papers?page=9